[(2R)-1-(4-bromothieno[2,3-c]pyridine-2-carbonyl)pyrrolidin-2-yl]-piperazin-1-ylmethanone;2,2,2-trifluoroacetic acid

C19H20BrF3N4O4S — CID 166397926

IUPAC[(2R)-1-(4-bromothieno[2,3-c]pyridine-2-carbonyl)pyrrolidin-2-yl]-piperazin-1-ylmethanone;2,2,2-trifluoroacetic acid
SMILESO=C(O)C(F)(F)F.O=C([C@H]1CCCN1C(=O)c1cc2c(Br)cncc2s1)N1CCNCC1
InChIInChI=1S/C17H19BrN4O2S.C2HF3O2/c18-12-9-20-10-15-11(12)8-14(25-15)17(24)22-5-1-2-13(22)16(23)21-6-3-19-4-7-21;3-2(4,5)1(6)7/h8-10,13,19H,1-7H2;(H,6,7)/t13-;/m1./s1
InChIKeyGVXKQYHQVYNOKN-BTQNPOSSSA-N
MW537.36 g/mol
LogP2.73
Rot. Bonds2

About [(2R)-1-(4-bromothieno[2,3-c]pyridine-2-carbonyl)pyrrolidin-2-yl]-piperazin-1-ylmethanone;2,2,2-trifluoroacetic acid

[(2R)-1-(4-bromothieno[2,3-c]pyridine-2-carbonyl)pyrrolidin-2-yl]-piperazin-1-ylmethanone;2,2,2-trifluoroacetic acid (PubChem CID 166397926) has the molecular formula C19H20BrF3N4O4S and a molecular weight of 537.36 g/mol. Its IUPAC name is [(2R)-1-(4-bromothieno[2,3-c]pyridine-2-carbonyl)pyrrolidin-2-yl]-piperazin-1-ylmethanone;2,2,2-trifluoroacetic acid.

Molecular Properties

Compound Name[(2R)-1-(4-bromothieno[2,3-c]pyridine-2-carbonyl)pyrrolidin-2-yl]-piperazin-1-ylmethanone;2,2,2-trifluoroacetic acid
PubChem CID166397926
Molecular FormulaC19H20BrF3N4O4S
Molecular Weight537.36 g/mol
Exact Mass536.03
IUPAC Name[(2R)-1-(4-bromothieno[2,3-c]pyridine-2-carbonyl)pyrrolidin-2-yl]-piperazin-1-ylmethanone;2,2,2-trifluoroacetic acid
SMILESO=C(O)C(F)(F)F.O=C([C@H]1CCCN1C(=O)c1cc2c(Br)cncc2s1)N1CCNCC1
InChIInChI=1S/C17H19BrN4O2S.C2HF3O2/c18-12-9-20-10-15-11(12)8-14(25-15)17(24)22-5-1-2-13(22)16(23)21-6-3-19-4-7-21;3-2(4,5)1(6)7/h8-10,13,19H,1-7H2;(H,6,7)/t13-;/m1./s1
InChIKeyGVXKQYHQVYNOKN-BTQNPOSSSA-N
XLogP2.73
TPSA102.84 Ų
H-Bond Donors2
H-Bond Acceptors6
Rotatable Bonds2
Heavy Atoms32
Complexity—

Lipinski Rule of Five

1 violation

RuleValue
MW ≤ 500537.36
LogP ≤ 52.73
H-Bond Donors ≤ 52
H-Bond Acceptors ≤ 106

Analyze [(2R)-1-(4-bromothieno[2,3-c]pyridine-2-carbonyl)pyrrolidin-2-yl]-piperazin-1-ylmethanone;2,2,2-trifluoroacetic acid with MolForge

Explore ADMET properties, 3D molecular structure, drug-likeness score, and discover similar compounds using our AI-powered platform.

Launch Full Analysis

Frequently Asked Questions

What is the IUPAC name of [(2R)-1-(4-bromothieno[2,3-c]pyridine-2-carbonyl)pyrrolidin-2-yl]-piperazin-1-ylmethanone;2,2,2-trifluoroacetic acid?
The IUPAC name of [(2R)-1-(4-bromothieno[2,3-c]pyridine-2-carbonyl)pyrrolidin-2-yl]-piperazin-1-ylmethanone;2,2,2-trifluoroacetic acid (CID 166397926) is [(2R)-1-(4-bromothieno[2,3-c]pyridine-2-carbonyl)pyrrolidin-2-yl]-piperazin-1-ylmethanone;2,2,2-trifluoroacetic acid.
What is the SMILES notation for [(2R)-1-(4-bromothieno[2,3-c]pyridine-2-carbonyl)pyrrolidin-2-yl]-piperazin-1-ylmethanone;2,2,2-trifluoroacetic acid?
The canonical SMILES for [(2R)-1-(4-bromothieno[2,3-c]pyridine-2-carbonyl)pyrrolidin-2-yl]-piperazin-1-ylmethanone;2,2,2-trifluoroacetic acid is O=C(O)C(F)(F)F.O=C([C@H]1CCCN1C(=O)c1cc2c(Br)cncc2s1)N1CCNCC1.
What is the InChIKey of [(2R)-1-(4-bromothieno[2,3-c]pyridine-2-carbonyl)pyrrolidin-2-yl]-piperazin-1-ylmethanone;2,2,2-trifluoroacetic acid?
The InChIKey is GVXKQYHQVYNOKN-BTQNPOSSSA-N. The full InChI is InChI=1S/C17H19BrN4O2S.C2HF3O2/c18-12-9-20-10-15-11(12)8-14(25-15)17(24)22-5-1-2-13(22)16(23)21-6-3-19-4-7-21;3-2(4,5)1(6)7/h8-10,13,19H,1-7H2;(H,6,7)/t13-;/m1./s1.
What are the key properties of [(2R)-1-(4-bromothieno[2,3-c]pyridine-2-carbonyl)pyrrolidin-2-yl]-piperazin-1-ylmethanone;2,2,2-trifluoroacetic acid?
[(2R)-1-(4-bromothieno[2,3-c]pyridine-2-carbonyl)pyrrolidin-2-yl]-piperazin-1-ylmethanone;2,2,2-trifluoroacetic acid has a molecular weight of 537.36 g/mol, XLogP of 2.73, 2 rotatable bonds, 2 hydrogen bond donors, and 6 hydrogen bond acceptors.
Where does this data come from?
All data for [(2R)-1-(4-bromothieno[2,3-c]pyridine-2-carbonyl)pyrrolidin-2-yl]-piperazin-1-ylmethanone;2,2,2-trifluoroacetic acid is sourced from PubChem (CID 166397926), the world's largest open chemistry database maintained by the National Library of Medicine (NIH).